BlackRock Fund Advisors’s Lisata Therapeutics LSTA Stock Holding History

BlackRock Fund Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Buy	102 +36	+55%	+$2.07K	﹤0.01%	4086
2016 Q3	$5K	Sell	66 -4	-6%	-$322	﹤0.01%	4067
2016 Q2	$6K	Sell	70 -646	-90%	-$59.4K	﹤0.01%	4063
2016 Q1	$81K	Sell	716 -54	-7%	-$5.31K	﹤0.01%	3712
2015 Q4	$125K	Buy	770 +36	+5%	+$6.61K	﹤0.01%	3681
2015 Q3	$164K	Buy	734 +291	+66%	+$73K	﹤0.01%	3556
2015 Q2	$124K	Sell	443 -4,152	-90%	-$1.54M	﹤0.01%	3690
2015 Q1	$1.75M	Buy	4,595 +280	+6%	+$152K	﹤0.01%	3156
2014 Q4	$2.44M	Buy	4,315 +594	+16%	+$404K	﹤0.01%	3128
2014 Q3	$3.09M	Sell	3,721 -185	-5%	-$162K	﹤0.01%	3011
2014 Q2	$3.82M	Buy	+3,906	New	+$3.8M	﹤0.01%	2982

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Fund Advisors's LSTA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Lisata Therapeutics (LSTA) stake by 55% in Q4 2016, buying an estimated $2.07K and bringing the position to 102 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4086.

BlackRock Fund Advisors first reported a position in LSTA in Q2 2014 and has held it in 11 quarters since. The position peaked at $3.82M in Q2 2014. 30 funds tracked by Wall St. Rank hold LSTA as of Q4 2016.

BlackRock Fund Advisors held 102 shares of Lisata Therapeutics worth $4K as of Q4 2016.
BlackRock Fund Advisors bought 36 Lisata Therapeutics shares in Q4 2016, an estimated $2.07K.
Lisata Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4086 holding.
BlackRock Fund Advisors first reported a position in Lisata Therapeutics in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Lisata Therapeutics position peaked at $3.82M in Q2 2014.
30 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.